Literature DB >> 26365402

Possible pulmonary Rhizopus oryzae infection in a previously healthy child after a near-drowning incident.

Magdalena M Gerlach1, Norman Lippmann2, Louise Kobelt1, Stefanie Petzold-Quinque1, Lutz Ritter3, Wieland Kiess1, Manuela Siekmeyer4.   

Abstract

This article reports on a previously healthy 17-month-old boy who developed pulmonary mucormycosis after a near-drowning incident in a goose pond. The patient survived without neurological sequelae and recovered, under treatment with amphotericin B, from the rare and often invasive fungal infection with Rhizopus spp., usually occurring in immunodeficient patients.

Entities:  

Keywords:  Cooling procedure; Near-drowning; Pulmonary mucormycosis; Rhizopus spp.

Mesh：

Substances：

Year:  2015        PMID： 26365402     DOI： 10.1007/s15010-015-0839-x

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  10 in total

1.  In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.

Authors:  Nikolaos G Almyroudis; Deanna A Sutton; Annette W Fothergill; Michael G Rinaldi; Shimon Kusne
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

2.  Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication.

Authors:  A P van Dam; M T C Pruijm; B I J Harinck; L B S Gelinck; E J Kuijper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

3.  [Retrospective analysis of 44 childhood drowning accidents].

Authors:  Caroline Brüning; Werner Siekmeyer; Manuela Siekmeyer; Andreas Merkenschlager; Wieland Kiess
Journal:  Wien Klin Wochenschr       Date:  2010-07-08       Impact factor: 1.704

Review 4.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

5.  Zygomycosis: an emerging fungal infection with new options for management.

Authors:  Carol A Kauffman; Anurag N Malani
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

6.  Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report.

Authors:  B Serio; R Rosamilio; V Giudice; P Zeppa; S Esposito; R Fontana; S Annunziata; C Selleri
Journal:  Infez Med       Date:  2012

7.  Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis.

Authors:  R Y Chinn; R D Diamond
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

Authors:  O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; T Freiberger; J Guinea; J Guarro; S de Hoog; W Hope; E Johnson; S Kathuria; M Lackner; C Lass-Flörl; O Lortholary; J F Meis; J Meletiadis; P Muñoz; M Richardson; E Roilides; A M Tortorano; A J Ullmann; A van Diepeningen; P Verweij; G Petrikkos
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

9.  Fatal disseminated mucormycosis in an immunocompotent patient: a case report and literature review.

Authors:  Amir Hossein Sarrami; Mehrdad Setareh; Masoud Izadinejad; Noushin Afshar-Moghaddam; Mohammad Mehdi Baradaran-Mahdavi; Mohsen Meidani
Journal:  Int J Prev Med       Date:  2013-12

10.  Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case report.

Authors:  Ana Vidovic; Valentina Arsic-Arsenijevic; Dragica Tomin; Irena Djunic; Radoslav Jakovic; Zlatibor Loncar; Aleksandra Barac
Journal:  J Med Case Rep       Date:  2013-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.